Profile | GDS2987 / GI_13376997-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 66.4 | 73 |
GSM215244 | HMVEC_vehicle_rep2 | 105 | 76 |
GSM215253 | HMVEC_vehicle_rep3 | 87.8 | 75 |
GSM215254 | HMVEC_atorvastatin_rep1 | 81.8 | 74 |
GSM215282 | HMVEC_atorvastatin_rep3 | 107.9 | 76 |
GSM215344 | HMVEC_atorvastatin_rep2 | 106.8 | 76 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 94 | 75 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 84.6 | 74 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 100.7 | 75 |
GSM215294 | HMVEC_SLx2119_rep1 | 77.1 | 75 |
GSM215295 | HMVEC_SLx2119_rep2 | 115.9 | 77 |
GSM215296 | HMVEC_SLx2119_rep3 | 60.1 | 66 |
GSM215297 | PASMC_vehicle_rep1 | 15.7 | 24 |
GSM215298 | PASMC_vehicle_rep2 | 62 | 65 |
GSM215310 | PASMC_vehicle_rep3 | 21.9 | 34 |
GSM215311 | PASMC_atorvastatin_rep1 | 34.3 | 51 |
GSM215312 | PASMC_atorvastatin_rep2 | 69.8 | 68 |
GSM215313 | PASMC_atorvastatin_rep3 | 7.5 | 12 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 54.8 | 64 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 27.8 | 47 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 23.1 | 38 |
GSM215328 | PASMC_SLx2119_rep2 | 33.7 | 52 |
GSM215329 | PASMC_SLx2119_rep3 | 55.8 | 67 |
GSM215330 | Fibroblasts_vehicle_rep1 | 14.6 | 33 |
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 7.1 | 24 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 9.5 | 25 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | ||
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | ||
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 10.2 | 32 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 18.1 | 45 |
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | ||
GSM215341 | Fibroblasts_SLx2119_rep3 | 4.3 | 11 |